GIP: Takes it up a notch with up to 22% weight loss and even greater fat-burning power for a more sculpted body
Metabolic Syndrome: A post hoc analysis revealed that patients achieving 15% weight loss had a significant decrease in the prevalence of metabolic syndrome, from 8091% at baseline to 2028% at Week 40/52
Kopetz S , Grothey A, Ciardiello F, Desai J, Kim TW, Maughan T, Cutsem EV, Wasan HS, Yaeger R, Yoshino T, Gollerkeri A, Edwards M, Lizaso MR, Tabernero J
Available online at: Summary Keywords weight loss, nutrient intake, glucagon-like peptide-1 receptor agonists, nutrition, diet, dietary reference intakes Citation Johnson B, Milstead M, Thomas O, McGlasson T, Green L, Kreider R and Jones R (2025) Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study
For certain conditions, and yes, are prescribed for other off-label effects
Ann Clin Psychiatry 5:1015 Stahl SM (2007) Novel therapeutics for depression: l-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent